Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) Short Interest Update

Therapeutic Solutions International, Inc. (OTCMKTS:TSOIGet Rating) was the recipient of a large decline in short interest in the month of December. As of December 30th, there was short interest totalling 10,000 shares, a decline of 95.4% from the December 15th total of 215,800 shares. Based on an average trading volume of 8,056,500 shares, the short-interest ratio is currently 0.0 days.

Therapeutic Solutions International Stock Performance

Shares of TSOI stock opened at $0.01 on Thursday. Therapeutic Solutions International has a twelve month low of $0.00 and a twelve month high of $0.04. The business’s 50 day moving average is $0.01 and its two-hundred day moving average is $0.01.

About Therapeutic Solutions International

(Get Rating)

Therapeutic Solutions International, Inc focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, traumatic brain injury, and lung pathologies, as well as for daily health. Its flagship products include QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production.

Featured Stories

Receive News & Ratings for Therapeutic Solutions International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Therapeutic Solutions International and related companies with MarketBeat.com's FREE daily email newsletter.